#news #biotech Idorsia spins out of J&J-Actelion with $1B and multidrug pipeline, sees shares jump 30% on first day of trading

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Idorsia spins out of J&J-Actelion with $1B and multidrug pipeline, sees shares jump 30% on first day of trading .Idorsia has spun out of Actelion after Johnson & Johnson wrapped up its $30 billion takeover of the Swiss biotech. The new company starts life with $1 billion in cash, multiple clinical-phase drugs and a deal with J&J, strengths that prompted traders to drive up its share price by 30% in its first hours on the Swiss stock exchange.

from FierceBiotech: Biotech http://ift.tt/2s8Uhgz